Karthik Veeravalli is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the production and identification of proteins. With a total of 6 patents to his name, Karthik's work has the potential to impact various applications in medicine and research.

Latest Patents

Karthik's latest patents include innovative methods for producing two-chain proteins in prokaryotic host cells. These methods enable the production of polypeptides, such as antibodies, by utilizing expression from extra-chromosomal polynucleotides and chaperone proteins from the host cell chromosome. Additionally, he has developed methods for identifying bacteria that comprise binding polypeptides, which can lead to improved expression and stability of these proteins. His inventions also encompass engineered bacteria suitable for these methods and libraries of binding polypeptide variants.

Career Highlights

Karthik Veeravalli is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.

Collaborations

Some of Karthik's notable coworkers include Michael W. Laird and Rebekah Mckenna. Their collaborative efforts have likely played a role in advancing the research and development of Karthik's patented technologies.

Conclusion

Karthik Veeravalli is a distinguished inventor whose work in protein production and identification is paving the way for advancements in biotechnology. His innovative patents and collaborations reflect his commitment to enhancing scientific knowledge and applications in the field.

This text is generated by artificial intelligence and may not be accurate.